Differences in the inhibition of translation by cisplatin, transplatin, and certain related compounds

Biochemical Pharmacology

Volumn 52, Issue 12, 1996, Pages 1895-1902

  Sato, Paul H ^c   Rosenberg, Jeffrey M ^a   Sato, Ronald I ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b AntiVirals   (United States)

^c NONE

Author keywords

chloroethylenetriamine platinum; cisplatin; heavy metals; protein synthesis inhibition; translation inhibition; transplatin

Indexed keywords

CISPLATIN; CYCLIC AMP; HEAVY METAL; MERCURIC CHLORIDE; METHIONINE; RADIOISOTOPE; TRANSPLATIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ISOMER; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA TRANSLATION;

EID: 0030600587     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00663-6     Document Type: Article

References (22)

1. 1. Harder HC and Rosenberg B, Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro. Int J Cancer 6: 207-216, 1970.
2. 2. Howle JA and Gale GR, Cis-dichlorodiammineplatinum (II): Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. Biochem Pharmacol 19: 2757-2762, 1970.
3. 3. Pinto AL and Lippard SJ, Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta 780: 167-180, 1985.
4. 4. Corda Y, Job C, Anin M-F, Leng M and Job D, Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry 30: 222-230, 1991.
5. 1 cells as a model for cis-diamrmnedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents. Cancer Res 48: 6017-6024, 1988.
6. 6. Montine TJ and Borch RF, Role of endogenous sulfur-containing nucleophiles in an in vitro model of cis-diamminedichloroplatinum(II)-induced nephrotoxicity. Biochem Pharmacol 39: 1751-1757, 1990.
7. 7. Rosenberg J and Sato P, Messenger RNA loses the ability to direct in vitro peptide synthesis following incubation with cisplatin. Mol Pharmacol 33: 611-616, 1988.
8. 8. Rosenberg JM and Sato PH, Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex. Mol Pharmacol 43: 491-497, 1993.
9. 9. Sato P and Rosenberg J, Cisplatin inhibition of translation. Curr Top Mol Pharmacol 1: 75-96, 1993.
10. 10. Ishikawa T and Ali-Osman F, Glutathione-associated cis-diamminedichloroplatinum(Il) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 268: 20116-20125, 1993.
11. 11. McBrien DCH and Slater TF (Eds.), Biochemical Mechanisms of Platinum Antitumor Drugs. IRL Press, Oxford, England, 1986.
12. 2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755, 1990.
13. 13. Roberts JJ and Friedlos F, Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: Relationship to toxicity. Pharmacol Ther 34: 215-246, 1987.
14. 14. Reed E, Cisplatin. In: Cancer Chemotherapy and Bioiogical Response Modifiers Annual 11 (Eds. Pinedo HM, Longo DL and Chabner BA), pp. 90-96. Elsevier Science, New York, 1990.
15. 15. Macquet JP, Butour JL, Johnson NP, Razaka H, Salles B, Vieussens C and Wright M, Is DNA the real target of antitumor platinum compounds? In: Platinum Coordination Complexes in Cancer Chemotherapy (Eds. Hacker MP, Douple EB and Krakoff IH), pp. 27-38. Martinus Nijhoff Publishing, Boston, 1984.
16. 16. Leibbrandt MEI, Wolfgang GHI, Metz AL, Ozobia AA and Haskins JR, Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 48: 761-770, 1995.
17. 17. Macquet JP and Butour JL, Platinum-amine compounds: Importance of the labile and inert ligands for their pharmacological activities toward L1210 leukemia cells. J Natl Cancer Inst 70: 899-905, 1983.
18. 18. Hurst R, Schatz JR and Matts RL, Inhibition of rabbit reticulocyte lysate protein synthesis by heavy metal ions involves the phosphorylation of the α-subunit of the eukaryotic initiation factor 2. J Biol Chem 262: 15939-15945, 1987.
19. 19. Matts RL, Schatz JR, Hurst R and Kagen R, Toxic heavy metal ions activate the heme-regulated eukaryotic initiation factor-2α kinase by inhibiting the capacity of heminsupplemented reticulocyte lysates to reduce disulfide bonds. J Biol Chem 266: 12695-12702, 1991.
20. 20. Watt GW and Cude WA, Diethylenetriamine complexes of platinum(II) halides. Inorg Chem 7: 335-338, 1968.
21. 21. Maniatis T, Fritsch EF and Sambrook J, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982.
22. 4